2023 International Congress Archives - Page 81 of 186

Ultra long-term outcome of deep brain stimulation (DBS) compared to botulinum toxin (BoNT) treatment in cervical dystonia (CD)

IM. Wedding, V. Siewers, IM. Skogseid (Oslo, Norway)
Ultrasound-guided selective diagnostic nerve block in patients with elbow spasticity: a retrospective pilot study.

E. Bianchini, A. Massimiani, J. Bemporad, M. Giovannelli (Rome, Italy)
UMSARS versus laryngoscopy-based assessment of dysphagia

N. El Fassi, A. Pavy-Le-Traon, E. Mouchon, O. Rascol, W. Meissner, A. Foubert-Saumier, Y. Gallois, S. Tessier, F. Ory-Magne, V. Woizard, M. Fabbri (Toulouse, France)
Uncovering the mechanisms of genotype by environment interaction in an idiopathic Parkinson’s disease model in Drosophila

P. Olguin, G. Olivares, N. Candia, F. Núñez-Villegas, A. Klein (Santiago, Chile)
Understanding caffeine consumption in Huntington’s Disease

J. Adrissi, S. Brooker, A. Mcbride, D. Larson, E. Gausche, D. Bega (Los Angeles, USA)
Understanding neuropsychological features of dopa responsive dystonia in children

R. Rattihalli, A. Nemeth, K. Scarff, M. Kurian (Oxford, United Kingdom)
Understanding Parkinson’s Disease Patients’ and Carepartners’ Palliative Care Knowledge & Preferences

M. Dini, S. Seshadri, S. Norton, A. Job, A. Contento, J. Holtrop, N. Yarab, B. Kluger (Miami, USA)
Understanding patient perceptions of advanced Parkinson’s disease (aPD) treatments

J. Domingos, R. Pahwa, A. Antonini, I. Malaty, S. Lindvall, F. de Renzis, C. Yan, K. Pantiri, N. Touba, E. Evans, A. Alobaidi, A. Shewale, M. Shah, P. Kukreja, J. Zamudio, K. Chaudhuri (Orpington Kent, United Kingdom)
Understanding rehabilitation care utilization in Parkinson’s disease

J. Goldman, T. Williams-Wood, H. Peirce, D. Merkitch (Chicago, USA)
Understanding Social Isolation before, during and after the Covid-19 pandemic among Patients with Parkinson’s disease

A. Mehta, S. Ng, N. Chia, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan (Singapore, Singapore)
Understanding the Mechanisms of Brain Dysfunction when Performing the Mental Rotation Task (MRT) in Stage 1 and Stage 2 EOPD using brain imaging

J. Razzaque, B. Mullen, C. Dougherty, A. Cotton, D. Wagner, S. Ravi, K. Le, K. Iyer, M. Subramanian, J. Wang, K. Venkiteswaran, T. Subramanian, P. Eslinger (Toledo, USA)
Underutilization of Neurology and Rehabilitation Services among People with Parkinson’s Disease

M. Kafri, B. Naamneh Abuelhija, M. Kestenbaum, SM. Giveon, G. Yogev Seligmann (Haifa, Israel)
Unilateral GPi DBS in Secondary Myoclonus-Dystonia Syndrome after Acute Disseminated Encephalomyelitis: A Case Report

A. Calvano, L. Timmermann, L. Beccaria, D. Pedrosa (Marburg, Germany)
Unique consecutive order of brain atrophy in spinocerebellar ataxia type 3 (SCA3)

J. Faber, T. Klockgether, H. Baumeister, D. Berron (Bonn, Germany)
Unsupervised multimodal digital assessment of fatigue and sleep disorders in Parkinson’s disease: the IDEA-FAST study

A. Pilotto, J. Kudelka, L. Correia, E. Lirani-Silva, J. Jimenez Ramos, S. Labrecque, R. Romijnders, C. Hansen, C. Maetzler, A. Rizzardi, C. Zatti, U. Funken, W. Remmele, A. Santos, S. Del Din, L. Rochester, J. Ferreira, A. Padovani, A. Yarnall, K. Seppi, F. Ng, W. Maetzler (Brescia, Italy)
Unsupervised physical capacity testing at home: a systematic review

D. de Graaf, S. Thissen, A. Van'T Hul, N. de Vries, B. Bloem (Nijmegen, Netherlands)
Unusual Neuronal Intranuclear Inclusion Disease (NIID) with initial presentation mimicking recurrent Transient Global Amnesia (TGA)

S. Kim, WT. Yoon (Seoul, Republic of Korea)
Unveiling the Link between Stress-Related Disorders and Dysautonomic Symptoms in Parkinson’s Disease: A Cross-Sectional Study

EJ. Acosta-Espinoza, IA. Ortiz-Marroquin, DI. Salinas-Leal, A. Salinas-Blancas, HM. Macias-Cruz, D. Martinez-Ramirez (Monterrey, Mexico)
Unveiling the role of subthalamic nucleus stimulation on freezing of gait in Parkinson disease using wearable sensors

R. Barbosa, P. Pita Lobo, A. Valadas, P. Bastos, S. Alberto, L. Correia Guedes, M. Rosa, R. Matias, M. Coelho (Toulouse, France)
Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease

J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Updates on the Outcomes of Botulinum Toxin Injections in Patients with Lower Limb Dystonia

M. Wajid, J. Yu, J. Frey, J. Lopes, A. Dave, L. Kugler, T. Stiep, J. Toledo, A. Ramirez-Zamora, A. Rawls, A. Wagle Shukla, I. Malaty (Gainesville, USA)
Uremic encephalopathy (UE) mimicking acute bulbar stroke with progression from bradykinesia to choreic movements in a diabetic patient undergoing hemodialysis: A case report

B. Qazimllari, A. Kuqo, J. Tana, A. Rroji, A. Rama, A. Verlaku, J. Kruja (Tirana, Albania)
Usability of Parkinson’s KinetiGraph in deep brain stimulation for essential tremor

E. Jiltsova, D. Nyholm (Uppsala, Sweden)
Use and Misuse of the Unified Multiple System Atrophy Rating Scale

A. Ferreirós, S. Castillo-Torres, M. Merello (Buenos Aires, Argentina)
Use of a wearable vibration-based device for the treatment of Parkinson’s disease tremor

C. Stephen, E. Fabara, F. Parisi, B. Pugliese, G. Vergara-Diaz, P. Gochyyev, A. Davanzo, D. Carballo, K. Pina, T. Luu, P. Bonato (Boston, USA)
Use of concomitant medications before and after treatment with levodopa/carbidopa intestinal gel in patients with advanced Parkinson’s disease: summary of phase 3 and real-world studies

J. Boyd, H. Fernandez, W. Poewe, A. Fasano, N. Kovács, K. Chaudhuri, M. Simu, J. Aldred, L. Lopiano, S. Parashos, J. Parra, L. Bergmann, P. Kukreja, M. Shah, O. Ladhani, G. Melzi, C. Yan, A. Antonini (Burlington, USA)
Use of insect model to study Parkinson’s disease pathophysiology by inducing GSH-depletion and behavioral deficits among larvae: Evidences of ameliorative properties of phytoconstituents

G. Chandran, R. D'Silva, M. Muralidhara (MYSURU, India)
Use of levodopa-carbidopa intestinal gel to treat a patient with multiple system atrophy (MSA)

A. Ferreira, S. Marques, A. Vieira, M. Coelho, G. Carneiro, M. Rodrigues (Braga, Portugal)
Use of stimview technology in deep brain stimulation of Parkinson´s disease patients

A. Rodríguez-Sanz, S. Serrano López, B. Mansilla, M. Román, JF. Paz (Madrid, Spain)
Use of the Dysphagia Handicap Index (DHI) patient reported outcomes measure in Parkinson disease and cervical dystonia

A. Silbergleit (Birmingham, USA)
User Experience (UX): Successful Remote Engagement Strategy for Individuals at Risk for Parkinson’s Disease in PPMI

L. Lemon, R. Dobkin, M. Kuhl, K. Fabrizio, C. Stanley, L. Heathers, C. Hobbick, B. Mcmahon, M. Totten, K. Marek (New Haven, USA)
using latent class mixed modelling to profile Parkinson’s disease patients at risk of cognitive decline

D. Pourzinal, R. Lawson, A. Yarnall, D. Burn, C. Williams-Gray, R. Barker, J. Yang, K. Mcmahon, J. O'Sullivan, G. Byrne, N. Dissanayaka (Herston, Australia)
Using Long read sequencing to identify complex structural variants in PRKN-PD

K. Daida, M. Funayama, A. Miano-Burkhardt, L. Mailik, K. Billingsley, M. Ishiguro, H. Yoshino, K. Ogaki, G. Oyama, R. Nonaka, W. Akamatsu, C. Blauwendraat, N. Hattori (Bethesda, USA)
Using mediation analysis to account for the effect of Parkinson’s Disease medications on disease progression

T. Liu, W. Lu, M. Yang, Y. Zhu, T. Dam, W. Hirst (Cambridge, USA)
Using wearable wireless technology to understand the natural history of adrenomyeloneuropathy in both clinic and home settings: 1-year follow-up in the CYGNET study

C. Bergner, W. Koehler, J. Bonkowsky, C. Stephen, F. Eichler, L. Glenn, M. Engelen (Leipzig, Germany)
Utility and safety of same day discharge after Deep Brain Stimulator Electrode Implantation: a feasibility study

S. Pardakhtim, M. Marsans, S. Srivastal, J. Roberts, F. Farrokhi (Seattle, USA)
Utility of neurophysiological markers in clinical management of subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson’s disease (PD)-a case report.

K. Markopoulou, P. Warnke (Evanston, USA)
Utility of quantitative EEG during sleep as a potential biomarker of Lewy body disease progression

E. Matar, K. Ehgoetz Martens, R. Grunstein, A. D'Rozario, S. Lewis (Sydney, Australia)
Utilization pattern and factors associated with amantadine use in Parkinson’s disease (PD) of the French NS-Park cohort

M. Fabbri, S. Tessier, V. Rousseau, JC. Corvol, A. Sommet, F. Tubach, Y. de Rycke, N. Bertille, Y. Selvarasa, S. Carvalho, C. Brefel-Courbon, F. Ory-Magne, O. Rascol (Blagnac, France)
Utilizing Speech Analysis to Differentiate Progressive Supranuclear Palsy from Parkinson Disease

K. Kang, A. Nunes, M. Sharma, A. Hall, R. Mishra, J. Casado, R. Cole, G. Barchard, A. Vaziri, A. Wills, A. Pantelyat (Baltimore, USA)